Concordance Between Healthcare Providers and Expert Consensus Recommendations in the Management, Monitoring, and Mitigation of Adverse Events Associated with CAR T-Cell Therapy: An Updated Analysis

This poster, presented at SITC 2020, describes updated results of recent CCO analysis of clinical practice trends suggesting continued suboptimal management of toxicities associated with CAR T-cell therapy administration.


Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.


Cookie Settings